Related content

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Phase I Clinical Trial of Topotecan and Pegylated Liposomal Doxorubicin

By Garcia Agustin   Roman Lynda   Muderspach Laila   O'Meara Anne   Facio Grace   Edwards Susan   Burnett Alexander  

Cancer Investigation, Vol. 23, Iss. 8, 2005-11 ,pp. : 665-670

Informa Healthcare

Access to resources Recommend Favorite

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

By Verwaal Vic  

Annals of Surgical Oncology, Vol. 15, Iss. 9, 2008-09 ,pp. : 2426-2432

Springer Publishing Company

Access to resources Recommend Favorite

Phase II clinical trial with pegylated liposomal doxorubicin

By Poveda A.  

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 127-132

Informa Healthcare

Access to resources Recommend Favorite

Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

By Chua Terence  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1330-1336

Springer Publishing Company

Access to resources Recommend Favorite